<i>In silico</i> discovery and serological validation of <i>Trypanosoma cruzi</i>-specific B-cell epitopes for high-precision Chagas disease diagnosis.

Front Microbiol · 2026 · PMC13402459 · PMID 42516975

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Fisher's exact test indicated highly significant differences across all groups ( p < 0.0001), reinforcing the potential of epitope 5 as a reliable diagnostic marker.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;i&gt;In silico&lt;/i&gt; discovery and serological validation of &lt;i&gt;Trypanosoma cruzi&lt;/i&gt;-specific B-cell epitopes for high-precision Chagas disease diagnosis.

The sentences

<i>In silico</i> discovery and serological validation of <i>Trypanosoma cruzi</i>-specific B-cell epitopes for high-precision Chagas disease diagnosis.